531762 UNJHAFOR

Unjha Formulations Share Price

₹25.05 +0.06 (0.24%)

12 Mar, 2025 07:25

SIP TrendupStart SIP in UNJHAFOR

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume

Investment Returns

  • Over 1 Month + 0.16%
  • Over 3 Month -22.33%
  • Over 6 Month -10.18%
  • Over 1 Year + 13.09%
SIP Lightning

Smart Investing Starts Here Start SIP with Unjha Formulations for Steady Growth!

Invest Now

Unjha Formulations Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Unjha Formulations Financials

Unjha Formulations Technicals

EMA & SMA

Current Price
₹25.05
+ 0.06 (0.24%)
pointer
  • stock-down_img
  • Bearish Moving Average 8
  • stock-up_img
  • Bullish Moving Average 8
  • 20 Day
  • ₹24.63
  • 50 Day
  • ₹26.27
  • 100 Day
  • ₹27.29
  • 200 Day
  • ₹26.53

Resistance and Support

24.98 Pivot Speed
  • R3 27.84
  • R2 26.86
  • R1 25.96
  • S1 24.08
  • S2 23.10
  • S3 22.20

What's your outlook on Unjha Formulations?

You can only vote for once

Unjha Formulations Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-02-04 Quarterly Results
2024-11-08 Quarterly Results
2024-08-01 Quarterly Results
2024-05-17 Audited Results
2024-03-29 Others

Unjha Formulations F&O

Unjha Formulations Shareholding Pattern

No data available.

About Unjha Formulations

  • NSE Symbol
  • UNJHAFOR
  • BSE Symbol
  • 531762
  • ISIN
  • INE576D01015

Similar Stocks to Unjha Formulations

Unjha Formulations FAQs

Unjha Formulations share price is ₹25 As on 12 March, 2025 | 07:11

The Market Cap of Unjha Formulations is ₹11.2 Cr As on 12 March, 2025 | 07:11

The P/E ratio of Unjha Formulations is 17.6 As on 12 March, 2025 | 07:11

The PB ratio of Unjha Formulations is 4.1 As on 12 March, 2025 | 07:11

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23